Obesity as a Cardiovascular Risk Factor: Assessment and Management

Obesity is a growing public health crisis. Obesity directly and indirectly (through comorbid conditions) leads to CVD, HF, and conduction defects that cause arrhythmias such as AF and SCD. Multiple guidelines for are available for managing obesity. All have similar recommendations to begin with lifestyle changes and counseling, with the addition of pharmacotherapy if needed. Most patients, especially those with severe obesity and/or comorbid conditions, will need long-term pharmacotherapy. Recent trials have shown clear benefits of weight loss on cardiac disease and CV comorbidities. Newer agents approved for managing obesity had positive CV outcomes in diabetes trials and there are ongoing CV outcomes trials for weight loss medications.

Share

Program Content

Activities

  • Assessment and Management
    Obesity as a Cardiovascular Risk Factor: Assessment and Management
    Video
    Congratulations: You achieved a completion on 04/09/2022

    Released: December 14, 2022

    Expires: December 14, 2023

Faculty

cover img faculity

Jean-Pierre Després, CQ, PhD, FAHA, FIAS

Professor, Department of Kinesiology, Faculty of Medicine
Scientific Director, International Chair on Cardiometabolic Risk
Université Laval
Scientific Director
VITAM – Research Centre for Sustainable Health
Québec (Québec) Canada

cover img faculity

Ian Neeland, MD, FAHA, FACC

Director, UH Center for Cardiovascular Prevention
Director, Translational Science Unit
Co-Director, Center for Integrated and Novel Approaches in Vascular-Metabolic Disease (CINEMA)
Harrington Heart and Vascular Institute
University Hospitals Cleveland Medical Center
Associate Professor of Medicine
Case Western Reserve University School of Medicine
Cleveland, OH

cover img faculity

Fatima Cody Stanford, MD, MPH, MPA, MBA, FAAP, FACP, FAHA, FAMWA, FTOS

Associate Professor of Medicine and Pediatrics
Harvard Medical School
Obesity Medicine Physician-Scientist
Neuroendocrine Unit, Pediatric Endocrinology, MGH Weight Center   
Equity Director, Endocrine Division, Department of Medicine
Director of Diversity
Nutrition Obesity Research Center at Harvard (NORCH)
Director, Anti-Racism Initiatives
Massachusetts General Hospital Neuroendocrine Unit
Core Faculty
Mongan Institute Disparities Solutions and Health Policy Research Centers
Leadership Team Massachusetts General Hospital Midlife Women’s Health Center
Boston, MA

Provided by

ProCE Banner
ProCE Banner

Jointly provided by the Potomac Center for Medical Education and Rockpointe.

Supporters

Supported by an educational grant from Novo Nordisk.

Novo Nordisk